Drawing for Serial No. 78537066

USPTO serial 78537066

Serial No. 78537066

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCCAULEY, BRENDAN D
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 78537066?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin St-Amant

MARTIN ST -AMANT CAIN LAMARRE CASGRAIN W QUEBEC; PROVINCE OF QUEBECG1R 2K2580 GRANDE-ALLEE E STE 440,

Goods and services

ClassDescriptionStatusFirst use
001Electro-active polymer made of ionic polymer, dielectric elastomer, ionic polymer-metal composite, ferroelectric polymer, liquid crystal elastomer, polymer gel, conductive polymer in the manufacture of medical devices; carbon nano tubes, namely tubular carbon molecules for use in the manufacture of medical devices not being electronic and mechanical applications; chemical compounds in the nature of electrorheological fluids and magnetorheological fluids for use in the manufacture of medical devicesACTIVE—
005Porous biomaterial, namely, base metal alloy Nickel-Titanium alloy, Titanium alloy, Titanium, Stainless steel, Cobalt based alloys, hydroxyapatite, alumina, glasses, glass-ceramics for use in the manufacture of dental implant material and devicesACTIVE—
006Porous biomaterial, namely, metal alloy, for use in the manufacture of medical implant material and devices; metal shape memory alloy for use in the manufacture of medical devicesACTIVE—
009Carbon nano tubes, namely tubular carbon molecules used in extremely small electronic and mechanical applications relating to medical devicesACTIVE—
010Prosthetic systems comprised of specialized mechanical components, specialized electronic boards and specialized artificial intelligence algorithms for the purposes of improving the quality of life of persons suffering form physical dysfunctions or impairments main component parts of the system-- DC motor, hydraulic actuation system, multi-stage mechanical transmission, micro-processor, digital signal processsor, sensor array, wireless communication technology, computer and embedded softwares; Orthotic system comprised of specialized biomechanical support, specialized electronic boards and specialized artificial intelligence algorithms for the purposes of improving the quality of life of persons suffering form physical dysfunctions or impairments and abnormal motion or position of the lower limb main component parts of the system-- DC motor, hydraulic actuation system, multi-stage mechanical transmission, micro-processor, digital signal processsor, sensor array, wireless communication technology, computer and embedded softwares; Mecatronic system comprised of specialized mechanical system, specialized electronic board and specialized artificial intelligence algorithms for the purposes of improving the quality of life of persons suffering from physical dysfunctions main component parts of the system-- DC motor, hydraulic actuation system, multi-stage mechanical transmission, micro-processor, digital signal processsor, sensor array, wireless communication technology, computer and embedded softwares; Biomedical devices, namely, nerve cuffs, control systems for regulating biological functions, namely, sensors for the nerves, to selectively measure neural signal; Feedback amplifiers and electrical stimulators of the nerves and muscles, surgical instruments, namely, surgical tools for use in implanting nerve cuffs and biomedical devices, namely, wires composed of silicone, stainless steel or platinum iridium; Biomedical equipment for use in medical procedures, namely, electrical leads, electrical power supplies, electronic signal processing units, software for signal transmission, hardware for signal transmission, namely, radio frequency and infrared transmitters and receivers, computer software for analyzing, calibrating and processing bioelectrical signals, hardware for analyzing, calibrating and processing bioelectrical signals, namely, electronic amplifiers, rectifiers, bin integrators, impedance meters, threshold detectors and computer software for controlling the stimulation of nervesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 18, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 18, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 17, 2006GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 17, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2005DOCKASSIGNED TO EXAMINER—
Jan 5, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance